Chitosan nanoencapsulation of Turbinaria triquetra metabolites in the management of podocyturia in nephrotoxic rats
2025

Chitosan Nanoencapsulation of Algal Metabolites to Treat Kidney Damage in Rats

Sample size: 66 publication 10 minutes Evidence: high

Author Information

Author(s): Abdel-Aal Abdullah, F. Abdel-Aziz A., El-khayat Zakaria, Mohamed Nadia, Rostom Merit, Tolba Emad, Galal El-Din Shams El-Din Nihal, Mettwally Walaa S.

Primary Institution: National Research Centre, Egypt

Hypothesis

The study aims to determine the effect of Turbinaria triquetra metabolites, either free or loaded on chitosan nanoparticles, against podocyturia and cisplatin nephrotoxicity in rats.

Conclusion

Chitosan nanoencapsulation showed better protective effects against kidney damage from cisplatin compared to free extracts.

Supporting Evidence

  • The ethyl acetate fraction and polysaccharides effectively reduced kidney damage in rats treated with cisplatin.
  • Nanoencapsulation improved the delivery and efficacy of the algal metabolites.
  • Histopathological examinations showed less kidney damage in treated groups compared to controls.

Takeaway

Researchers found that using tiny particles made from chitosan to deliver substances from seaweed can help protect rat kidneys from damage caused by a cancer drug.

Methodology

The study involved 66 male rats divided into 11 groups, with treatments including chitosan nanoparticles and various extracts, followed by assessments of kidney function and histopathology.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Male Wistar rats, 8-10 weeks old.

Statistical Information

P-Value

0.000

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/s41598-024-82463-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication